• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Pherin Pharmaceuticals, Inc. - Product Pipeline Review - Q4 2010 Product Image

Pherin Pharmaceuticals, Inc. - Product Pipeline Review - Q4 2010

  • ID: 1464012
  • December 2010
  • 28 pages
  • Global Markets Direct

Pherin Pharmaceuticals, Inc. – Product Pipeline Review – Q4 2010

Summary

Global Market Direct’s pharmaceuticals report, “Pherin Pharmaceuticals, Inc. - Product Pipeline Review - Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Pherin Pharmaceuticals, Inc. - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Pherin Pharmaceuticals, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including READ MORE >



List of Tables
List of Figures
Pherin Pharmaceuticals, Inc. Snapshot
Pherin Pharmaceuticals, Inc. Overview
Key Information
Key Facts
Pherin Pharmaceuticals, Inc. – Research and Development Overview
Key Therapeutic Areas
Pherin Pharmaceuticals, Inc. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pherin Pharmaceuticals, Inc. – Pipeline Products Glance
Pherin Pharmaceuticals, Inc. Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Pherin Pharmaceuticals, Inc.–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Pherin Pharmaceuticals, Inc. – Drug Profiles
PH80-HF
Product Description
Mechanism of Action
R&D Progress
PH80-PMD
Product Description
Mechanism of Action
R&D Progress
PH94B
Product Description
Mechanism of Action
R&D Progress
PH15
Product Description
Mechanism of Action
R&D Progress
PH10A
Product Description
Mechanism of Action
R&D Progress
PH284
Product Description
Mechanism of Action
R&D Progress
PH45
Product Description
Mechanism of Action
R&D Progress
Pherin Pharmaceuticals, Inc. – Pipeline Analysis
Pherin Pharmaceuticals, Inc. – Pipeline Products by Therapeutic Class
Pherin Pharmaceuticals, Inc. Pipeline Products By Target
Pherin Pharmaceuticals, Inc. – Pipeline Products by Route of Administration
Pherin Pharmaceuticals, Inc. – Locations And Subsidiaries
Head Office
Recent Developments
Feb 01, 2008: Pherin Phase IIb Clinical Trials With PH94B
Feb 01, 2008: Pherin Phase IIb Clinical Trials With PH94B
Dec 21, 2006: Pherin Pharmaceuticals Reports Favorable Phase II Data Showing Clinical Benefits of Novel Intranasal Medication PH80 to Treat Symptoms of Premenstrual Syndrome (PMS)
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Note: Product cover images may vary from those shown

RELATED PRODUCTS